Orlando Artificial Kidney Center is a medicare approved dialysis facility center in Altamonte Springs, Florida and it has 0 dialysis stations. It is located in Seminole county at 775 Gateway Drive, Altamonte Springs, FL, 32714. You can reach out to the office of Orlando Artificial Kidney Center at (407) 294-2456. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Orlando Artificial Kidney Center has the following ownership type - Profit. It was first certified by medicare in September, 1976. The medicare id for this facility is 102511 and it accepts patients under medicare ESRD program.
Name | Orlando Artificial Kidney Center |
---|---|
Location | 775 Gateway Drive, Altamonte Springs, Florida |
No. of Dialysis Stations | 0 |
Medicare ID | 102511 |
Managed By | Fresenius Medical Care |
Ownership Type | Profit |
Late Shifts | No |
775 Gateway Drive, Altamonte Springs, Florida, 32714 | |
(407) 294-2456 | |
Not Available |
NPI Number | 1487766226 |
Organization Name | Orlando Artificial Kidney Center |
Doing Business As | Bio-medical Applications Of Florida Inc |
Address | 775 Gateway Dr Altamonte Springs, Florida, 32714 |
Phone Number | (407) 294-2456 |
Dialysis patients with Hemoglobin data | 22 |
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 23 |
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 4 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 43 |
Adult patients getting regular peritoneal dialysis at the center | 42 |
Adult patient months included in Kt/V greater than or equal to 1.7 | 346 |
Percentage of adult patients getting regular peritoneal dialysis at the center | 95 |
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Orlando Artificial Kidney Center with elevated calcium levels.
Patients with hypercalcemia | 53 |
Hypercalcemia patient months | 442 |
Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
Patients with Serumphosphor | 53 |
Patients with Serumphosphor less than 3.5 mg/dL | 6 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 25 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 35 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 24 |
Patients with Serumphosphor greater than 7 mg/dL | 10 |
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 8 |
Patient months included in arterial venous fistula and catheter summaries | 67 |
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | 46 |
Hospitalization Rate in facility | 210.3 (As Expected) |
Hospitalization Rate: Upper Confidence Limit | 384.3 |
Hospitalization Rate: Lower Confidence Limit | 120.7 |
The rate of readmission show you whether patients who were being treated regularly at Orlando Artificial Kidney Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
Readmission Rate in facility | 10.6 (As Expected) |
Readmission Rate: Upper Confidence Limit | 28 |
Readmission Rate: Lower Confidence Limit | 2.4 |
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Orlando Artificial Kidney Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
Patients in facility's Transfusion Summary | 42 |
Transfusion Rate in facility | 44.7 (As Expected) |
Transfusion Rate: Upper Confidence Limit | 155.7 |
Transfusion Rate: Lower Confidence Limit | 14.9 |
The rate of mortality show you whether patients who were being treated regularly at Orlando Artificial Kidney Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
Patients in facility's Survival Summary | 195 |
Mortality Rate in facility | 14.1 (As Expected) |
Mortality Rate: Upper Confidence Limit | 25.9 |
Mortality Rate: Lower Confidence Limit | 6.8 |
Orlando Artificial Kidney Center Location: 775 Gateway Drive, Altamonte Springs, Florida, 32714 Phone: (407) 294-2456 |
BMA - North Orlando Location: 750 S North Lake Blvd Ste 1024, Altamonte Springs, Florida, 32701 Phone: (407) 831-7070 |